Viewing Study NCT04964505


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2026-06-30 @ 9:11 PM
Study NCT ID: NCT04964505
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-08-01
First Post: 2021-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia
Sponsor: Brian Jonas
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
Keywords: